Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough

Summary

Study of the efficacy, safety, and tolerability of serlopitant for the treatment of refractory chronic cough

Timeline

Start

2017-10-03

Primary completion

2018-08-15

Completion

2018-09-06

Outcome

Missed primary endpoint

registry analysis (superiority test); Serlopitant 5 mg vs Placebo; p = 0.9942; Mean Difference (Final Values) 31.4; Mixed Models Analysis NCT03282591 ↗

Drugs

Indications